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ABSTRACT: 
Coronavirus M proteins represent the 
major protein component of the viral 
envelope. They play an essential role during 
viral assembly by interacting with all the 
other structural proteins. Coronaviruses bud 
into the endoplasmic reticulum (ER)–Golgi 
intermediate compartment (ERGIC), but the 
mechanisms by which M proteins are 
transported from their site of synthesis, the 
ER, to the budding site remain poorly 
understood. Here, we investigated the 
intracellular trafficking of the Middle East 
respiratory syndrome coronavirus (MERS-
CoV) M protein. Subcellular localization 
analyses revealed that the MERS-CoV M 
protein is retained intracellularly in the 
trans-Golgi network (TGN), and we 
identified two motifs in the distal part of the 
C-terminal domain as being important for 
this specific localization. We identified the 
first motif as a functional diacidic DxE ER 
export signal, since substituting Asp-211 and 
Glu-213 with alanine induced retention of 
the MERS-CoV M in the ER. The second 
motif, 199KxGxYR204, was responsible for 
retaining the M protein in the TGN. 
Substitution of this motif resulted in MERS-
CoV M leakage toward the plasma 
membrane. We further confirmed the role of 
199KxGxYR204 as a TGN retention signal by 
using chimeras between MERS-CoV M and 
the M protein of infectious bronchitis virus 
(IBV). Our results indicated that the C-
terminal domains of  both proteins determine 
their specific localization, namely, TGN and 
ERGIC/cis-Golgi for MERS-M and IBV-M, 
respectively. Our findings indicate that 
MERS-CoV M protein localizes to the TGN 
because of the combined presence of an ER 
export signal and a TGN retention motif. 
 
Coronaviruses are widespread 
pathogens that can infect a wide variety of 
species among mammals and birds (1, 2), 
including humans, causing mostly 
respiratory and enteric symptoms. There are 
6 known coronaviruses infecting humans. 
The first human coronaviruses HCoV-229E 
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and HCoV-OC43 were isolated in the 60s 
from patients suffering from a common cold. 
Administration of these viruses to volunteers 
rapidly confirmed their harmless character. 
Therefore, research on coronaviruses had 
been mostly of veterinary interest, but this 
changed recently with the emergence of two 
highly pathogenic human coronaviruses 
causing severe pneumonia epidemics. First, 
the severe acute respiratory syndrome 
coronavirus (SARS-CoV) appeared in 2002, 
then the Middle East respiratory syndrome 
coronavirus (MERS-CoV) appeared in 2012. 
Both viruses have a zoonotic origin showing 
that this virus family is a reservoir of 
emerging pathogens, especially because of 
their high interspecies transmission (3).  
Coronaviruses are enveloped positive 
single-stranded RNA viruses, with a very 
large genome of 25-30kb, belonging to the 
Coronaviridae Family in the Nidovirales 
order. The viral particle is composed of a 
lipid envelope in which at least three 
structural proteins are anchored: the spike 
protein (S), the envelope protein (E) and the 
membrane protein (M). Inside the particle, 
the viral RNA is associated with the 
nucleocapsid protein (N) forming a helical 
capsid. The S protein triggers viral entry by 
binding to the cellular receptor and 
mediating fusion of the viral envelope with 
the host cell membrane (4, 5). The E protein 
is a small protein with multiple roles during 
infection (6). The SARS-CoV E protein 
plays an important role in viral pathogenesis, 
and this role can be linked to the ion channel 
activity of the protein (7). The E protein is 
also involved in viral assembly, trafficking 
and egress of virions, by promoting 
membrane curvature, viral fission, and by 
inducing morphological changes of the 
compartments of the secretory pathway (8, 
9).   
The M protein is the most abundant protein 
of the envelope (10). Its length ranges from 
217 to 230 amino acid residues in most 
coronaviruses, but it can go up to 270 
residues in some coronaviruses (Bottlenose 
Dolphin Coronavirus). It is a protein with 
three membrane-spanning hydrophobic 
segments, a small N-terminal domain located 
outside the virion (or inside the lumen of 
intracellular organelles) and a large C-
terminal domain that makes up half of the 
protein, inside the virion (or in the cytoplasm 
of infected cells) (10). M proteins of some 
Alphacoronaviruses contain an additional 
hydrophobic segment that functions as a 
signal peptide. The M protein is invariably 
glycosylated on its amino-terminal domain. 
However, there are differences in the type of 
glycosylation. The murine hepatitis virus 
(MHV) and some other Betacoronavirus M 
proteins are O-glycosylated whereas Alpha- 
and Deltacoronavirus M proteins are 
modified with N-linked sugars. The 
glycosylation is dispensable for virus 
assembly (11). The M protein is considered 
to be the motor of the assembly of viral 
particles since it is able to interact with all of 
the other structural proteins (12–14). 
Important M-M interactions have also been 
demonstrated during assembly (15, 16). For 
many coronaviruses, including the 
transmissible gastroenteritis virus (TGEV), 
MHV and IBV, the co-expression of M and 
E proteins in cells is sufficient to induce the 
production of virus-like particles (VLPs) 
(17–19), indicating that these proteins are 
essential and sufficient to the assembly step. 
Only for SARS-CoV, the nucleocapsid 
protein has been shown to be additionally 
required for the production of VLPs (20). 
Electron microscopy observations have 
shown that coronaviruses bud inside the ER-
Golgi intermediate compartment (ERGIC) 
(21, 22) and then travel through the Golgi. 
Although the assembly step of coronaviruses 
occurs in the ERGIC compartment, it has 
been shown for several coronaviruses that 
the M protein expressed alone in cells can go 
beyond the assembly site in the secretory 
pathway (21). However, the subcellular 
localization of the M protein varies between 
the different coronavirus species. Indeed 
MHV M protein can reach the trans-Golgi 
network (TGN) whereas IBV-M protein is 
retained in the ERGIC and one or two 
cisternae of the cis-Golgi (21, 23, 24). The 
intracellular retention of IBV-M has been 
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attributed to the first membrane-spanning 
segment and particularly to polar residues 
located within this domain (25, 26). For 
MHV, both the TM1 and the last 22 amino 
acids seem to be important determinants for 
the intracellular localization of the protein 
(27). The aim of this study was to investigate 
the subcellular localization of the MERS-M 
protein and to characterize the signals 
involved in its trafficking.   
 
Results 
MERS-CoV M localizes in the Trans-Golgi 
network. 
The M protein is composed of a short N-
terminal domain followed by 3 membrane-
spanning segments and a long C-terminal 
domain (Figure 1A). In order to analyze the 
intracellular trafficking of the MERS-CoV 
M protein, we transfected a vector 
expressing the MERS-CoV M protein with a 
HA tag fused at its N-terminus (HA-MERS-
M) in HeLa cells, and compared the protein 
localization with different compartment 
markers using immunofluorescence and 
confocal microscopy (Figure 1B). As 
observed in Figure 1B, MERS-CoV M 
shows a good colocalization with TGN46 
that localizes in the trans-Golgi network. We 
confirmed this colocalization by co-
transfection of the M protein with the GFP 
fused to the transmembrane domain and 
cytosolic tail of the cation-independent 
mannose-6-phosphate receptor (GFP-CI-
MPR). This reporter has been shown to be 
localized in the TGN in HeLa cells (28). The 
images were then analyzed using ImageJ to 
calculate the Pearson Correlation Coefficient 
(PCC) for each co-staining (Figure 1C). The 
PCC measures the pixel-by-pixel covariance 
of the signal levels of two images (29). The 
PCC values range from -1 to 1. A PCC value 
of 1 is obtained for two images whose 
intensities of fluorescence are linearly and 
perfectly related whereas a value of -1 means 
that the intensities are inversely related to 
one another. Values near 0 mean that the 
intensities are uncorrelated. Our results 
confirm the localization of MERS-CoV M in 
the TGN with a PCC of 0.878 (+/-0.014) and 
0.852 (+/-0.012) for the MERS-CoV M with 
TGN46 and GFP-CI-MPR markers, 
respectively. The PCC for MERS-CoV M 
and CD4 (a cell surface marker), or the 
calreticulin (an endoplasmic reticulum (ER) 
marker) are below 0.4. However, the PCC 
between MERS-CoV M and the ERGIC 
marker, ERGIC-53 is higher (0.524 +/-0.03). 
To facilitate the detection of the M protein 
and particularly in co-staining experiments, 
different M protein constructs were 
generated with different tags either at the N-
terminus (HA or V5) or at the C-terminus 
(V5 or VSVG). This offers the advantage of 
using a panel of antibodies raised in different 
species. In order to use these tools, we 
analyzed their intracellular localization to 
confirm that adding a tag, regardless of their 
sequence or the position of the insertion, had 
no effect on MERS-CoV M localization. We 
also generated a polyclonal antibody raised 
against a C-terminal peptide of the M protein 
to detect the untagged protein. This antibody 
was used to control the effect of the tags on 
the subcellular localization of the M protein. 
Cells expressing M or the different tagged 
versions of this protein were processed for 
double-label immunofluorescent detection of 
the M protein and TGN46 (Figure 1D). For 
each protein, the colocalization level with 
the TGN46 marker was also quantified by 
calculating the PCC (Figure 1E). As 
observed with HA-M, the untagged form of 
the protein presented a strong colocalization 
with the TGN46 marker (Figure 1D and 1E) 
with a PCC of 0.857 (+/-0.015). Similar 
results were obtained with the other tagged 
proteins. Altogether, these results indicate 
that the MERS-CoV M protein expressed 
alone is located in the TGN and that the tag 
added to our constructs does not alter this 
localization.   
 
The last 20 residues of the C-terminal 
domain of the MERS-CoV M protein are 
important for the MERS-CoV M 
intracellular trafficking. 
To study the role of the C-terminal domain 
of MERS-CoV M in its intracellular 
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trafficking, we constructed serial deletion 
mutants of 20 residues. The deletion of the 
last 20 residues of the MERS-CoV M protein 
(M∆20) produced mutants that were no 
longer localized in the TGN (figure 2A). 
Moreover it induced a different intracellular 
localization depending on the tag used. 
Indeed, HA-M∆20 co-localizes with 
calreticulin, the ER marker, as shown by the 
double labeling in Figure 2B; whereas 
M∆20-VSVG was located at the cell surface 
as shown by the double labeling of M∆20-
VSVG and CD4 (Figure 2C). We measured 
the extent of colocalization for HA-M∆20 or 
M∆20-VSVG with the ER, TGN or cell 
surface marker by measuring the PCC 
(Figure 2D). The wild-type protein presented 
a PCC of 0.905 (+/-0.007) for TGN46 and of 
0.296 (+/-0.014) and 0.239(+/-0.017) for 
CRT and CD4, respectively. The HA-M∆20 
protein showed a decrease of the PCC for 
TGN46 (0.369+/-0.019) associated with an 
increase of the PCC with CRT (0.855+/-
0.011). The HA-M∆20 also showed a 
moderate increase in cell surface localization 
with a PCC for CD4 of 0.539(+/-0.018). The 
PCC between M∆20-VSVG and TGN46 was 
also strongly decreased (0.331+/-0.025), 
however the M∆20-VSVG protein presented 
a strong increase of the PCC for CD4 
(0.79+/-0.016) and a moderate increase of 
the PCC for CRT (0.475+/-0.018). These 
results suggest that important intracellular 
trafficking motifs are present in the distal 
part of the C-terminal domain of MERS-
CoV M. Analysis of the sequence of the last 
20 residues showed that the deleted sequence 
contains a potential di-acidic ER export 
signal at position 211-213 (211DIE213). This 
signal was first characterized for the 
glycoprotein of VSV and is indeed present in 
the VSVG tag (YTDIEMNRLGK) used in 
our experiments. It is likely that a blockade 
of ER export arose from the deletion in HA-
M∆20 and the loss of the DxE signal, 
however the addition of the VSVG tag in the 
M∆20-VSVG protein restored the signal and 
rescued the ER export. Moreover, the M∆20-
VSVG protein was mainly located at the cell 
surface instead of being retained in TGN, 
suggesting that the distal part of the C-
terminal domain of the M protein also 
contains a determinant responsible for its 
localization in the TGN. 
 
DxE is a functional ER export signal for 
MERS-CoV M.  
To confirm the role of the DxE signal in the 
ER export of the MERS-M protein, we 
mutated the aspartic acid and glutamic acid 
into alanine (D211A, E213A) in the M 
protein fused with an N-terminal HA tag 
(HA-M-DxE) or with a C-terminal VSVG 
tag (M-DxE-VSVG), and analyzed the 
subcellular localization of the mutants in 
confocal microscopy. Similarly to HA-
M∆20, HA-M-DxE was mainly localized in 
the ER, whereas M-DxE-VSVG was 
localized in the TGN (Figure 2B and 2A), 
confirming that the VSVG tag is able to 
compensate the D211A-E213A mutation. 
This result demonstrates that the DxE signal 
present in the C-terminal domain of MERS-
CoV M protein is a functional ER export 
signal involved in the trafficking of the 
protein.  
 
Four residues in the C-terminal domain 
mediate MERS-CoV M localization to the 
TGN. 
The presence of the DxE signal explained 
the exit of the M protein from the ER but not 
its retention in the trans-Golgi, since it is 
commonly accepted that in non-polarized 
cells, the constitutive secretory pathway 
leads to the plasma membrane by default (i.e 
in absence of specific addressing/retention 
signals). Considering that and the fact that 
the M∆20-VSVG protein migrates to the cell 
surface, we looked for the presence of 
another signal in the last 20 amino acids of 
the cytosolic tail which could be involved in 
the retention of MERS-CoV M in the TGN 
compartment. For this purpose, we 
constructed three smaller C-terminal deletion 
mutants lacking 5, 10 or 15 residues, but 
keeping the VSVG tag to rescue the ER 
export. These mutants were called M∆5, 
M∆10 and M∆15. We then compared the 
subcellular localization of these mutants to 
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the wild-type and M∆20 M proteins (Figure 
3A, 3B and 3C). Similar to what was 
observed for the wild-type M and in contrast 
to M∆20 protein, the M∆5, M∆10 and M∆15 
proteins co-localized with the TGN46 
marker, indicating that the 5 amino acids 
sequence AGNYR, located between the ∆20 
and ∆15 deletions is likely involved in the 
specific localization of the protein in the 
TGN. To identify the residues involved in 
the TGN localization of the protein, each 
amino acid (except the alanine) was mutated 
individually into alanine in the M∆15 
protein. M∆15-G201A, M∆15-N202A, 
M∆15-Y203A and M∆15-R204A were 
expressed in HeLa cells and the subcellular 
localization of the proteins was analyzed by 
fluorescence microscopy (Figure 4). The 
proteins carrying the mutations G201A, 
Y203A or R204A showed a reduced 
colocalization with the TGN46 marker 
compared to the M∆15 (Figure 4A and 4C), 
with partial export of the protein to the cell 
surface (Figure 4B and 4C). This difference 
in intracellular trafficking is illustrated by a 
decrease of PCC between the M mutants and 
TGN46 associated with an increase of the 
PCC with CD4. These results indicate a role 
of these three residues in the localization of 
the protein in the TGN. The mutation N202A 
had no effect on the subcellular localization 
of the protein compared to the wild type. To 
confirm these results, the mutations G201A, 
Y203A or R204A were also inserted in the 
full-length protein. Analysis of the 
subcellular localization of these mutants is 
shown in Figure 5. M-G201A, M-Y203A 
and M-R204A showed a reduced co-
localization with TGN46 compared to the 
wild-type M-VSVG and an increase of cell 
surface expression resulting in an increase of 
the PCC between the mutant and CD4. To 
ensure that we identified the full motif 
involved in the TGN localization of the 
protein, we also mutated 3 conserved 
residues (Y195, R197 or K199) among the 
Betacoronaviruses located upstream of the 
∆20 deletion. Interestingly, mutation of the 
residue K199 also resulted in an increase of 
the cell surface expression of the protein 
(Figure 5). 
We also constructed a quadruple mutant 
protein, M-K199A, G201A, Y203A, R204A 
(M-KGYR). The extent of colocalization of 
the quadruple mutant (M-KGYR) with 
TGN46 and CD4 was in the same range than 
those of the single mutants.  
 
To confirm the cell surface expression of the 
M protein when the residues K199, G201, 
Y203 and R204 are mutated, we performed a 
cell surface biotinylation assay. The MERS-
M protein contains a N-glycosylation site in 
its N-terminal domain (MSNMTQLTE), 
consequently the migration profile of the 
MERS-M protein in immunoblot renders the 
quantification of the protein amount difficult 
(see Figure 6C), so we also mutated the N-
glycosylation site in the different mutants. 
First, we verified that introducing the 
mutation N3Q had no effect on the 
intracellular localization of the different 
proteins (M, M∆20, M-DxE, M-K199A, M-
G201A, M-Y203A, M-R204A and M-
KGYR; data not shown). Plasma membrane 
proteins in cells expressing the different 
mutants were labeled with non-permeable 
biotin, then biotinylated proteins were 
precipitated with streptavidin-conjugated 
agarose beads and analyzed in immunoblot 
(Figure 6A and 6B). The M protein is only 
weakly expressed at the cell surface, with 
less than 1% of the total amount of protein 
expression at the cell surface. Mutation of 
the residues K199, G201, Y203 and R204 
alone or in combination induced an increase 
in cell surface detection of the M protein 
with approximately 13% of the total amount 
of N3Q-M-KGYR located at the cell surface. 
Single mutations induced only moderate 
increases of the cell surface expression 
compare to the quadruple mutant. The N3Q-
M-DxE was barely detected at the cell 
surface. As seen in immunofluorescent 
colocalization assay (Figure 6B), the 
expression of the N3Q-M∆20 mutant at the 
cell surface was slightly increased compared 
to the wild-type protein. Together, these 
results indicated that the residues K199, 
G201, Y203 and R204 of MERS-CoV M are 
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involved in its specific localization in the 
TGN.  
 
We also investigated the N-glycosylation 
status of the DxE and KxGxYR mutants. In 
immunoblot, the wild-type protein migrated 
as 3 bands (Figure 6C). A first band of 
around 20-25 kDa corresponds to the 
unglycosylated M protein, confirmed by the 
migration profile of the protein in which the 
N-glycosylation site was abolished by 
mutation (N3Q-M) and by treatment with 
PNGase F. A second band of approximately 
30 kDa and a third more diffuse band 
migrating more slowly were also observed. 
As expected, the second band is sensitive to 
Endoglycosidase H treatment, showing that 
this band corresponds to M proteins 
glycosylated in the ER that have not reached 
the Golgi yet. The more diffuse band was not 
sensitive to EndoH treatment, suggesting that 
this form is further modified in the Golgi. 
Only one band was observed with the DxE 
mutant with a high-intensity at 30 kDa 
sensitive to EndoH . The EndoH sensitivity 
of the 30 kDa band likely reflects the 
accumulation of this protein in the ER due to 
the lack of export signal. 
It is worth noticing that the migration profile 
of the M-KGYR mutant in western blot 
showed an increased N-glycosylation 
consistent with a better trafficking through 
the Golgi (Figure 6C). 
All together these results confirm the 
presence of two intracellular trafficking 
motifs in the C-terminal domain of the 
MERS-CoV M protein: first the DxE motif 
is responsible for the ER export of the 
protein, then a second motif KxGxYR is 
involved in its retention in the TGN. 
 
KxGxYR is a not an internalization signal 
and is not involved in M oligomerization.  
Intracellular trafficking is a dynamic process 
with proteins that can undergo cycles of cell 
surface expression and internalization. At 
steady state, the localization of proteins at 
the plasma membrane results from an 
equilibrium between anterograde 
intracellular trafficking and retrieval of 
protein by endocytosis. Any inhibition of 
endocytosis would result in protein 
accumulation at the cell surface. To test if 
the KxGxYR motif is an endocytosis signal, 
we analyzed the endocytosis of the M 
protein in a biotinylation assay. Proteins 
expressed at the plasma membrane of cells 
expressing N3Q-M or N3Q-M-KGYR were 
labeled at 4°C with a non-permeable 
cleavable biotin, then endocytosis was 
allowed by incubating the cells at 37°C for 
30 min. Non-internalized biotin was then 
cleaved with glutathione and internalized 
proteins were detected in immunoblot. As 
shown in Figure 6E and 6F, we did not 
detect any difference in endocytosis levels 
between the wild-type protein and M-
KGYR.  
It has been proposed that oligomerization of 
MHV-M protein could be involved in its 
TGN retention. Indeed mutants that do not 
form oligomers were detected at the cell 
surface. In cell lysates, the mutant N3Q-M-
KGYR forms dimer in comparable amount 
to the wild-type protein (Figure 6D). We also 
analyzed the formation of N3Q-M-KGYR 
oligomers at the cell surface. To do so, the 
cell proteins at the cell surface were 
biotinylated and cross-linked. The formation 
of multimers was detected in immunoblot 
(Figure 6D). As previously shown, 
expression of N3Q-M-KGYR at the cell 
surface was increased. We detected the 
formation of dimers with a strong band 
migrating at 40 kDa and also the formation 
of higher oligomers for both proteins, 
suggesting that the increased cell surface 
expression conferred by the mutation of the 
motif KxGxYR is not due to a defect in M-
M interactions. 
These results indicate that the KxGxYR 
signal is not involved in M oligomerization 
and is not an internalization signal, and that 
the localization of MERS-CoV M in the 
TGN is likely due to a mechanism of 
retention, preventing the cell surface 
expression of the protein. 
 
 
IBV C-terminal domain is involved in its 
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ERGIC localization. 
To confirm the role of the KxGxYR as a 
retention signal in the TGN, we tried to 
transfer this signal on a protein expressed at 
the cell surface. We used CD4 as a reporter, 
however the chimeric proteins that were 
constructed presented folding defects (data 
not shown). CD4 is a type-I transmembrane 
protein whereas the M protein has a very 
different architecture with 3 transmembrane 
segments. Therefore, we constructed 
chimeras between MERS-CoV M and the M 
protein of another coronavirus, IBV. This 
way, we were able to construct chimeras that 
conserved the transmembrane domain 
structure of the protein, which is likely 
important for the folding and localization of 
the protein. The IBV-M protein expressed 
alone in cells is located in the ERGIC and 
cis-Golgi (26), so its localization can be 
distinguished from the one of MERS-CoV 
M, using specific compartment markers. In 
addition, it has been shown that the first 
transmembrane segment of IBV-M is 
involved in the intracellular retention of the 
protein. The amino acid sequences of the 
MERS- and IBV-M C-terminal extremity are 
not conserved and are rather different 
(Figure 7A). 
First, we constructed chimeras in which we 
switched the C-terminal domains of the 
proteins: MERS-M/IBV-M and IBV-
M/MERS-M or IBV-M/MERS-M-KGYR. 
We also replaced the first transmembrane 
segment of the MERS-M-KGYR with the 
one of IBV-M to test if the first 
transmembrane segment of IBV-M can 
retain MERS-M-KGYR intracellularly 
(TM1-IBV/MERS-M-KGYR). Finally, we 
replaced the first transmembrane segment of 
IBV-M with the one of MERS-CoV M. 
Schematic drawings of the different 
chimeras that were constructed are presented 
in Figure 7B. The subcellular localization of 
the chimeric proteins was then analyzed by 
fluorescence microscopy. As shown in 
Figure 8, the immunofluorescent staining of 
IBV-M and MERS-CoV M differed in their 
pattern, with a compact perinuclear staining 
for MERS-CoV M and a punctuated staining 
for IBV-M. Co-localization assessment of 
IBV-M with TGN46 and ERGIC-53 showed 
that the protein mainly localizes within the 
ERGIC. The MERS-M/IBV-M protein 
colocalized with the ERGIC-53 marker and 
not the TGN46 marker, and is thus located in 
the ERGIC (Figure 8C), whereas the IBV-
M/MERS-M protein colocalized with the 
TGN46 marker and not with the ERGIC-53 
marker, and is thus localized in the TGN. In 
other words, the switch of the C-terminal 
domains of the IBV-M and MERS-CoV M 
proteins caused a switch of their specific 
localizations, respectively to the ERGIC and 
the TGN. Interestingly, the IBV-M/MERS-
KGYR protein localized to the cell surface, 
confirming the role of the KxGxYR signal in 
the specific localization of the MERS-M 
protein to the TGN. This result also suggests 
that the first transmembrane segment of 
IBV-M is not able to retain MERS-M-
KGYR intracellularly. In accordance with 
this result, the chimera TM1-IBV/MERS-M-
KGYR was also located at the cell surface 
and the chimera TM1-MERS/IBV-M was 
located in the ERGIC compartment. These 
results are unexpected based on previous 
reports on the role of the first transmembrane 
segment of IBV-M in its intracellular 
retention. Moreover, these results indicate 
that for both MERS-CoV M and IBV-M, the 
presence of the C-terminal domain is critical 
to induce the specific localization of the 
protein. Furthermore, we also confirmed the 
involvement of the KxGxYR signal in the 
specific retention of MERS-CoV M to the 
TGN, even in the chimeric context.  	  
Discussion 
Viruses divert the intracellular trafficking 
machinery and studying the intracellular 
trafficking of viral membrane proteins often 
helps to decipher the mechanisms of protein 
sorting and leads to uncovering new sorting 
motifs. We investigated the intracellular 
trafficking of the MERS-CoV M protein and 
identified a well-known ER export signal. In 
addition, we identified a novel TGN 
retention motif.  
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Specific targeting of viral structural proteins 
to the assembly site in the cell is crucial for 
viral egress and spreading. The three 
envelope proteins of coronaviruses E, M and 
S are synthesized in the ER. Protein exit 
from the ER toward the Golgi occurs at 
specific sites called ER exit sites (ERES) and 
for most of the proteins relies on the coat 
protein complex II (COPII). Assembly of the 
coat starts with the activation of the GTPase 
Sar1 by Sec12, an integral ER guanine 
nucleotide exchange factor. This allows the 
recruitment of the complex Sec23/24 
forming the inner layer of the coat followed 
by the recruitment of the outer layer of the 
coat formed by Sec13/31 (30). ER export 
signals, including LxxLE, diacidic DxE, 
YNNSNP or triple R, can interact directly 
with Sec24 or Sar1 and lead to the 
recruitment of the COPII carriers (31). We 
identified a functional DxE motif in the C-
terminal part of the MERS-CoV M protein, 
and this signal is also present in the M 
protein of the porcine epidemic diarrhea 
virus (PEDV). Some Alpha- and 
Gammacoronavirus M proteins, such as 
HCoV-229E, HCoV-NL63, FIPV or IBV, 
contain a diacidic ExE motif, however it 
remains to be determined whether these 
signals can also act as ER export signal 
since, in the yeast protein Sys1p, ExE cannot 
compensate for the DxE signal (32).  
After its exit from the ER, the MERS-CoV 
M protein reaches the Golgi where the 
protein undergoes further modification of its 
N-glycans as shown in our glycosidase-
resistance assays. As previously shown for 
MHV-M protein, we and others (33) found 
that ectopically expressed MERS-CoV M 
protein is mainly located in the TGN at 
steady state. In the cells, the TGN is a 
sorting station where proteins are either sent 
to the cell surface or diverted toward other 
endomembrane compartments. The 
localization of proteins in specific 
biosynthetic compartments generally results 
from an equilibrium between anterograde 
and retrograde movements of the proteins. 
For example, in immunofluorescent labeling 
of the protein TGN38/46, the protein is 
located in the TGN but this localization is 
the consequence of a very dynamic process 
in which the protein is transported to the 
plasma membrane and recycled back to the 
TGN after internalization and sorting in 
endosomes. The SDYQRL motif in the C-
terminal domain of the protein is important 
for its retrieval from the cell surface (34). In 
addition, the transmembrane domain of the 
protein also participates in the TGN 
localization of the protein by mediating some 
retention in the TGN (35). An increase of the 
transport of the protein to the cell surface can 
lead to the saturation of the retrieval 
mechanism of the protein and its 
accumulation at the cell surface.   
Here, we identified a KxGxYR motif in the 
MERS-CoV M protein which is involved in 
the TGN localization of the protein. The 
mutation of any residue of this motif leads to 
the accumulation of the protein at the plasma 
membrane. This signal is highly conserved 
in the M proteins of Betacoronavirus. 
Interestingly, Armstrong et al. previously 
reported that deletion of the last 18 residues 
of the C-terminal domain of the MHV-M 
protein induced a shift of the protein 
localization toward the cell surface (36). 
Interestingly, this deletion is in the middle of 
the KxGxYR signal, leaving only the K and 
G residues on the truncated protein. In 
another study, Krijnse-Locker et al. also 
reported a deletion of 22 residues of the 
protein leading to the accumulation of the 
protein at the cell surface (27). Furthermore, 
in their study about the structure 
requirements of MHV-M protein, De Haan 
et al. mentioned that one of their mutant 
containing a mutation of the KxGxYR motif 
(Y211G) leaked to the cell surface (11). 
These data suggest that TGN localization of 
M proteins may be a general feature of the 
Betacoronaviruses and that the KxGxYR 
motif is involved in this localization. It has 
been reported that the SARS-CoV M protein 
is located in the Golgi, unfortunately its 
precise localization within the Golgi remains 
unclear (37, 38). 
Locker et al. reported that oligomerization of 
MHV-M protein is involved in the TGN 
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retention of the protein, however our results 
show that it is unlikely that the KxGxYR 
motif is involved in the oligomerization of 
the protein (39). As a small proportion of the 
MERS-CoV M protein could be detected at 
the cell surface (less than 1% of the total 
protein, see Fig 6A and 6B), we tested if the 
KxGxYR motif could be an endocytosis 
motif. The MERS-CoV M protein is 
retrieved from the cell surface by 
endocytosis, however we could not detect 
any defect of endocytosis of the M protein 
when the KxGxYR motif was mutated (Fig 
6E and 6F). This result argues against an 
endocytic function of this motif and suggests 
a role as a retention signal. Indeed, it was 
previously reported that the MHV-M protein	  
does not cycle between the plasma 
membrane of the cell and the TGN but rather 
acts as a TGN resident protein. Another 
hypothesis is a cycle of the M between the 
ER and the TGN with the KxGxYR motif 
acting as a retrieval signal from the TGN to 
the ER. The mutation of this signal would 
inhibit the retrieval of the protein allowing 
its trafficking to the cell surface. The 
retrograde trafficking ensures the constant 
recycling of proteins and lipids from the 
Golgi to the ER to maintain the their steady-
state distribution and the composition and 
function of the organelles themselves. Two 
distinct mechanisms are responsible for this 
retrograde transport. The first one is 
dependent on the coat protein complex I 
(COPI) and the second one is the COPI-
independent pathway that is less 
characterized, involves the Rab6 GTPase and 
is composed of tubular rather than vesicular 
carriers (40). The formation of the COPI-
coated vesicles starts with the recruitment en 
bloc of the coatomer composed of seven 
subunits by the Arf1 GTPase. Cargos carry 
specific signals in their cytosolic-exposed 
domain mediating their recruitment by 
COPI. The best characterized motifs are the 
di-lysine motifs KKxx or KxKxx that are 
recognized by the α-COP or β’-COP subunit 
of the coatomer. Multimeric proteins, such as 
receptors or channels, contains arginine-
based sorting signal (φRxR with φ 
representing any hydrophobic amino acid). A 
common feature of the motif involved in the 
protein sorting toward the COPI-dependent 
pathway is the presence of basic residues. 
Because of its content in basic residues, the 
KxGxYR motif might be recognized by the 
COPI machinery to prevent its cell surface 
expression.  
Nevertheless, the mechanism of action of the 
KxGxYR motif remains to be further 
elucidated, particularly in the context of the 
viral infection. Indeed, the retention of the 
protein may be important for the proper 
assembly of the viral particle by promoting 
interaction with the other viral membrane 
components. How the interaction with E or S 
may mask the KxGxYR retention signal or 
how these protein complexes may further 
traffic through the biosynthetic pathway 
remain to be clarified. 
Furthermore, we cannot exclude that other 
domains of the protein may also be 
implicated in the TGN localization of the 
protein. As mentioned above, the 
transmembrane domain and an endocytic 
motif cooperate for the proper localization of 
TGN38/46. The Golgi apparatus is a 
compartmentalized structure where 
glycosylation occurs in an ordered process 
(41). The successful completion of 
glycosylation relies in part on the proper 
distribution of glycosyltransferases along the 
Golgi that will permit their action in a 
sequential manner.	   Most of the 
glycosyltransferases are type II 
transmembrane proteins. They consist of a 
short N-terminal domain exposed in the 
cytosol, a transmembrane domain, a stem 
region and an enzymatic domain. The non-
uniform distribution of these enzymes in the 
Golgi is likely maintained by a combination 
of retention and recycling mechanisms (42). 
The mechanisms that ensure the localization 
of glycosyltransferases in the Golgi are 
numerous and diverse. These include the 
oligomerization status of the enzyme and 
complex formation, the length of the 
transmembrane domain but also its 
composition that may affect the way it is 
interacting with the different lipid 
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compositions that the protein encounters in 
the different Golgi cisternae. The cytosolic 
domains also contain motifs involved in the 
localization of the enzymes (42).  
To confirm the role of the KxGxYR motif as 
a retention signal in the TGN we attempted 
to transfer the motif in CD4, a protein 
expressed at the plasma membrane. 
Unfortunately, the different chimeras that we 
constructed were not folded properly. This is 
likely due to the difference of protein 
structures, CD4 being a type I 
transmembrane protein, whereas MERS-
CoV M is a triple membrane-spanning 
protein. Therefore, to further confirm the 
role of the KxGxYR motif, we constructed 
chimeras between MERS-CoV M and IBV-
M as they show clear differences in 
subcellular localization at steady-state. 
Indeed, IBV-M is mainly expressed in the 
ERGIC and cis-Golgi compartment. 
Previous studies reported the role of the first 
transmembrane segment in the intracellular 
retention of the protein (26). This was shown 
by the replacement of the transmembrane 
domain of the glycoprotein G of the 
vesicular stomatitis virus (VSVG) with the 
first transmembrane segment of IBV-M 
which resulted in the intracellular retention 
of the protein, and four polar residues were 
shown to mediate this retention (25). 
Surprisingly, when we replaced the first 
membrane-spanning domain of MERS-CoV 
M with the one of IBV-M in the context 
where the KxGxYR motif is mutated into 
alanine residues (TM1-IBV/MERS-M-
KGYR), the protein was not located in the 
ERGIC but was still transported to the cell 
surface. This difference may lie in the use of 
a full-length coronavirus M protein instead 
of a reporter protein such as VSVG. 
Interestingly, when we swapped the C-
terminal domains of the proteins, we also 
switched their specific localizations, 
suggesting that the IBV-M C-terminal 
domain contains signal(s) for the ERGIC 
localization of the protein, and not the first 
membrane segment as previously reported.  
Altogether, our results suggest that the C-
terminal domain of coronavirus M proteins 
dictates their specific localization, the 
Betacoronavirus M proteins being addressed 
to the TGN where they are retained by the 
action of the KxGxYR motif. The motif 
mediating IBV-M localization in the ERGIC 
and cis-Golgi compartment remains however 
to be determined. At this state of knowledge, 
we cannot exclude that the membrane-
spanning segments of the protein 
additionally participate in the intracellular 
retention of these proteins and cooperates 
with the C-terminal domain to prevent the 
expression of the protein at the cell surface.  
 
Experimental procedures 
Plasmids.  
The coding sequence of the M protein was 
cloned in the pCDNA3.1(+) vector, with or 
without a sequence coding for different tags, 
including HA, VSVG and V5. Total RNA 
from blood samples of infected patient were 
extracted by using the Nucleospin RNA kit 
(Macherey-Nagel) according to the 
manufacturer’s instructions. Then, reverse 
transcription was performed using the high 
capacity cDNA reverse transcription kit 
(Applied Biosystems) and the M protein 
sequence was amplified by two successive 
PCRs. First, the sequence was amplified by 
using the two following primers:  5’-
gacgagtgggtttaacgaact-3’ and 5’-
ggggatgccataacaatgaaa-3’. Then, to insert the 
sequence in expression vectors, the sequence 
was amplified with 5’-
tcggatccaccatgtctaatatgacgcaactcactg-3’ 
(primer A) and 
5’cagaattcctaagctcgaagcaatgcaa-3’  (primer 
B ; untagged protein) or by combination of 
primer A and 5’-
tagaattcagctcgaagcaatgcaagttcaat-3’ (primer 
C ; C-terminal tagged protein) or with 5’-
acggatccaatatgacgcaactcactgagg-3’ (primer 
D) with primer B (N-terminal tagged 
protein).  PCR products were inserted 
between the BamH1 and EcoR1 restriction 
sites of the different vectors.  
M protein deletion mutants were generated 
by PCR by using either primer A or D in 
combination with a reverse primer annealing 
at different positions of the M sequence, with 
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or without a stop codon with an EcoR1 
restriction site. M protein point mutants were 
generated by site-directed mutagenesis using 
PCR. Overlapping primers containing the 
mutation(s) of interest were designed and 
used for PCR on a MERS-M wild type 
template. PCRs were then gel-purified, 
digested and cloned into a pCDNA3.1-
VSVG or pCDNA3.1-HA plasmid. The 
chimeric constructions were generated by 
fusion PCR. For IBV-M/MERS-M-Ct, the 
sequence of IBV-M corresponding to 
residues 1 to 101 were amplified with the 
forward primer 5’-
ttaagctttccatgcccaacgagacaaattg-3’ and the 
reverse primer 5’-
taaacagccgaatactctggatccaataac-3’, 
containing 10 bases complementary to the 
MERS-M sequence at its 5’ extremity. The 
MERS-M sequence between the residues 
100 to 219 were amplified by PCR using the 
forward primer 5’-
ccagagtATTcggctgtttatgagaactgg-3’ 
containing 10 bases complementary to the 
IBV-M sequence, and with the primer D. 
Then the two PCR products were mixed and 
amplified using the forward primer that 
anneals the IBV-M sequence and the primer 
D. Using the same strategy of overlapping 
sequences for the internal primers, we 
constructed MERS-M/IBV-M-Ct composed 
of the MERS-M1-102 fused to IBV-M105-225 . 
The first transmembrane segment of the 
MERS-M-KGYR was replaced by the first 
transmembrane segment of IBV-M by fusing 
IBV-M1-42 to MERS-M-KGYR41-219 (TM1-
IBV/MERS-M-KGYR) and the first 
transmembrane segment of IBV-M was 
replaced by the first transmembrane segment 
of MERS-M by fusing MERS-M1-40 to IBV-
M43-225 (TM1-MERS/IBV-M). The PCR 
products were gel-purified and digested by 
BamH1 and EcoR1, and then inserted into 
the pCDNA3.1-V5 expression vector. All the 
constructs were verified by DNA 
sequencing. 
The plasmid coding the ERGIC-53 protein 
fused to the GFP and coding the GFP-CI-
MPR were kindly provided by Dr Hauri 
(University of Basel, Switzerland) and Dr 
Hoflack (University of Dresden, Germany) 
respectively. The plasmid encoding the CD4-
GFP fusion protein was constructed by 
amplification of the GFP with the two 
following primers 5’-
AGACATGTAGCCCCATTGTGAGCAAG
GGCGAGGAGCT-3’ and 5’- 
GGGTCGACTCACTTGTACAGCTCGTC
CATGC-3’ and then inserted into the PCI-
CD4 between the AflIII and SalI restriction 
sites. 
 
Cell culture and transfection.  
HeLa cells were maintained in MEM 
(Minimum Essential Medium) supplemented 
with 10% fetal calf serum (FCS) and 1% 
Glutamax. 24h before transfection, HeLa 
cells were plated in 24-well plates on 
coverslips or in 6 well plates. The next day, 
plasmids encoding wild-type M protein or M 
mutant protein were transfected into HeLa 
cells using TransIT®-LT1 Transfection 
Reagent (Mirus Bio).  
 
Immunofluorescence and confocal 
microscopy. 
At 18h post-transfection, cells were rinsed 
with PBS, fixed with 3% PFA and processed 
for immunofluorescence analysis. Cells were 
permeabilized with 0,1% Triton X100 in 
PBS for 5 min and then blocked containing 
10% goat or horse serum in PBS for 10 min. 
M protein was detected using anti-M pAbs 
(rabbit, Proteogenix) or anti-tag antibodies: 
anti-HA mAbs (3F10, Sigma Aldrich), anti-
VSVG mAbs (P5D4, produced in the lab of 
the authors) or anti-V5 mAbs (ThermoFisher 
Scientific). For co-localization experiments, 
cells were double-labeled for M-proteins and 
cellular marker, anti-calreticulin pAbs (CRT) 
for endoplasmic reticulum (ER) and anti-
TGN46 pAbs for TGN (Biorad). Primary 
antibodies were diluted in blocking buffer. In 
some cases, intracellular compartments were 
stained by transfecting an expression vector 
for a marker fused with the green fluorescent 
protein (GFP). For ERGIC and TGN 
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compartments, cells were co-transfected with 
M proteins and expression vectors for 
ERGIC53 and M6PR fused to GFP, 
respectively. For cell surface staining, cells 
were transfected with a vector expressing 
CD4 fused to GFP. After a 30 min 
incubation with primary antibodies, cells 
were washed 3 times for 5 min with PBS. 
Then the cells were incubated with 
fluorescent secondary antibodies (cyanine-3 
conjugated goat anti-mouse IgG; cyanine-3 
conjugated goat anti-rabbit IgG, alexa488 
conjugated donkey anti-rat IgG; cyanine-3 
conjugated donkey anti-sheep IgG; alexa488 
conjugated donkey anti-mouse IgG; 
alexa555 conjugated goat anti-rat IgG) and 1 
µg/ml of 4',6-diamidino-2-phenylindole 
(DAPI).  
Images were acquired using a laser scanning 
confocal microscope LSM 880 (Zeiss) using 
a 63x oil immersion objective. Signals were 
sequentially collected using single 
fluorescence excitation and acquisition 
settings to avoid crossover.  
The extent of colocalization was quantified 
by calculating the Pearson’s correlation 
coefficient (PCC) using the JACoP plugin of 
ImageJ. The PCC examines the relationship 
between the intensities of the pixels of two 
channels in the same image. For each 
calculation, at least 15 images were analyzed 
to obtain a PCC mean. A PCC of 1 indicates 
perfect correlation, 0 no correlation, and -1 
perfect anti-correlation.  
 
Biotinylation and internalization assay. 
HeLa cells were seeded in 6-well plates and 
transfected the next day with pCDNA3.1-
V5-N3Q-M, pCDNA3.1-V5-N3Q-MΔ 20, 
pCDNA3.1-V5-N3Q-M-D211A,E213A, 
pCDNA3.1-V5-N3Q-M-
K199A,G201A,Y203A,R204A, PCDNA3.1-
V5-N3Q-M-K199A, pCDNA3.1-V5-N3Q-
M-G201A, pCDNA3.1-V5-N3Q-M-Y203A 
or pCDNA3.1-V5-N3Q-M-R204A. At 24h 
post-transfection cells were rinsed on ice 
with ice-cold PBS, and incubated twice with 
250 µg/mL of EZ-Link™ Sulfo-NHS-SS-
Biotin (Pierce) diluted in PBS for 15 minutes 
in order to label cell surface proteins. 
Unfixed biotin was then quenched by two 
sequential incubations of the cells for 10 
minutes with 50 mM Glycine/PBS.  
For internalization assays, cells were 
biotinylated 48h post-transfection and then 
incubated at 37°C for 30 min. The biotin of 
non-endocytosed proteins was then cleaved 
upon three incubations of 20 min with 
glutathione buffer (50mM reduced 
glutathione, 75 mM NaCl, 75 mM NaOH, 
10% FCS) followed by two incubations of 
15 min with iodoacetamide buffer (50mM 
iodoacetamide, 1% BSA, PBS).  
Cells were then lysed with B1 buffer (50 
mM Tris pH 7.5, 100 mM NaCl, 2 mM 
EDTA, 1% Triton X-100, 0.1% SDS, 
protease inhibitors cocktail) on ice. Lysates 
were centrifuged at 14,000 rpm at 4°C for 5 
min to remove cellular debris, and were then 
incubated with 30 µL of streptavidin-
conjugated agarose beads (Sigma) for 2h. 
Beads were then washed serially with 1mL 
of buffers B1, B2 (50 mM Tris pH 7.5, 100 
mM NaCl, 2 mM EDTA, 0.1% Triton X-
100, 0.5% SDS, 0.5% DOC), B3 (50 mM 
Tris pH 7.5, 500 mM NaCl, 2 mM EDTA, 
0.1% Triton X-100) and B4 (50 mM Tris pH 
7.5, 100 mM NaCl, 2 mM EDTA). Proteins 
were resuspended in Laemmli loading buffer 
and detected by immunoblotting. Samples 
were separated by SDS-polyacrylamide gel 
electrophoresis (SDS-PAGE) and proteins 
were transferred on a nitrocellulose 
membrane (Amersham). Membrane-bound 
M proteins were then detected using a 
monoclonal anti-V5 antibody and 
horseradish peroxidase-conjugated 
secondary antibody.  Detection was carried 
out by chemiluminescence (Pierce). 
 
Glycosidases treatment. 
HeLa cells were transfected with vectors 
expressing V5-M, V5-M-DxE, V5-M-
KGYR or V5-N3Q-M proteins. 24h later, 
cells were lysed in B1 buffer. Then, 30 μl 
of lysates were mock-treated or treated with 
PNGase F or Endoglycosidase H according 
to the manufacturers instructions. Then 
proteins were separated on SDS-PAGE and 
detected by immunoblotting. 
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M-M interactions assay. 
HeLa cells were seeded in 10 cm dishes and 
transfected with vectors expressing V5-N3Q-
M or V5-N3Q-M-KGYR. The next day, cell 
surface proteins were biotinylated at 4 °C 
and cross-linked with 0.8% PFA in PBS for 
10 minutes. Then, PFA was quenched by 
washing the cells with 50 mM NH4CL/PBS 
twice. Cells were lyzed with B1 buffer and 
lysates were processed for streptavidin 
precipitation as previously described. 
Proteins were resuspended in non-reducing 
Laemmli loading buffer without heating and 
detected by immunoblotting.
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FIGURES 
Figure 1: Schematic drawing of the MERS-M protein with the sequence of residues 149-219 
of the C-terminal domain (1A). Subcellular localization of the MERS-CoV M protein (1B and 
1C). Cells expressing HA-tagged M protein in combination with the GFP-CI-MPR, ERGIC-
53-GFP or CD4 fused with GFP were labeled with an anti-HA antibody. GFP-CI-MPR is a 
TGN marker, ERGIC-53-GFP is an ER-Golgi intermediate compartment marker and CD4 is a 
protein expressed at the cell surface. To detect the ER compartment or the TGN, cells were 
double-labeled for HA and calreticulin (CRT) or TGN46 as indicated. Bars indicate 20 µm. 
Pearson’s correlation coefficients were calculated for each combination of co-staining. 
N-terminal or C-terminal added-tags have no effect on the TGN localization of the M protein 
(1D and 1E). Cells expressing untagged M protein (M), N- or C-terminally V5-tagged M 
protein (V5-M and M-V5 respectively), N-terminally HA-tagged M (HA-M) or C-terminally 
VSVG-tagged M (M-VSVG) were double-labeled with anti-M antibody together with an anti-
TGN46 antibody. Pearson’s correlation coefficients were calculated. 
 
Figure 2: The distal part of MERS-M C-terminal domain contains motif(s) involved in its 
subcellular localization. Cells expressing the M protein (HA-M and M-VSVG), or the M 
protein lacking its last 20 residues (HA-MΔ20 or MΔ20-VSVG) or the M protein with 
D211 and E213 mutated into A (HA-M-DxE or M-DxE-VSVG) were processed for detection 
of M protein using an anti-tag antibody. The TGN was detected by using an anti-TGN46 (2A) 
and the ER by using an anti-CRT antibody (2B). The plasma membrane was labeled by co-
expression of CD4 fused to GFP together with the M protein (2C). Bars indicate 20 µm. 
Pearson’s correlation coefficients were calculated for each combination of co-staining (2D). 
 
Figure 3: Subcellular localization of mutants with serial deletions of the distal part of the 
MERS-CoV M protein. M protein with a C-terminal VSVG tag (M) or M protein deleted of 5 
(MΔ5), 10 (MΔ10), 15 (MΔ15) or 20 amino acid residues (MΔ20) were expressed in 
HeLa cells and their localization either in the TGN or at the plasma membrane was 
investigated by double labeling with TGN46 (3A) or by co-expressing CD4 fused to GFP 
(3B). Bars indicate 20 µm. Pearson’s correlation coefficients were calculated for each 
combination of co-staining (3C). 
 
Figure 4: Identification of the MERS-CoV MΔ15 motif involved in its TGN localization. 
Amino acid residues G201, N202, Y203 and R204 located in the last 5 residues of MΔ15 
(located in TGN) were mutated individually into alanine and the subcellular localization of 
the mutants was analyzed as described in Figure 3. Bars indicate 20 µm. 
 
Figure 5: The KxGxYR motif is involved in MERS-M protein localization in TGN. The 
following mutations K199A, G201A, Y203A, R204A were introduced individually or 
together in the context of the full-length M protein with a C-terminal VSVG tag. The 
subcellular localization of the mutants was analyzed as described in Figure 3. Bars indicate 20 
µm. 
 
Figure 6: Cell surface expression of M protein mutants.  Plasma membrane proteins of cells 
expressing the different M protein mutants were labeled with non-permeable biotin. 
Biotinylated proteins were purified using streptavidin-conjugated agarose beads. Biotinylated 
M proteins and total M proteins in cell lysates were detected in immunoblot (6A) and 
quantified (6B). Results are expressed as the percentage of total M protein expressed at the 
cell surface and are expressed as the mean of five independent experiments. Error bars 
represent the standard error of the means (SEM). Results were analysed by using an ANOVA 
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test (* P<0.1; ** P<0.01; *** P<0.001; **** P< 0.0001). Glycosylation of M protein mutants. 
Lysates of cells expressing the M protein or the M protein with the ER export signal mutated 
(M-DxE) or the TGN localization motif mutated (M-KGYR) were treated with EndoH or 
PNGase F. A lysate of cells expressing the M protein with its N-glycosylation site mutated 
(N3Q) was left untreated. N-terminal tagged proteins were detected by Western Blotting with 
an anti-V5 antibody (6C).  
Endocytosis of M protein and M-KGYR. Cells were transfected with vectors expressing the 
M and M-K199A-G210A-Y203A-R204A (M-KGYR) proteins. Then cell surface proteins 
were labeled with non-permeable biotin at 4°C. Endocytosis was allowed by incubating the 
cells for 30 min at 37°C. Biotin of non-internalized proteins was cleaved with glutathione. 
Internalized M protein was detected after purification with streptavidin-conjugated agarose 
beads in immunoblot (6E). In each experiment, each condition was performed in duplicate. 
For cell surface associated protein, only 25% of the sample was loaded on the gel. For the 
controls of glutathione cleavage (without any internalization, 0 min) and for the samples 
internalized (30 min), the totality of the samples were loaded on the gel. Internalized M 
protein was quantified. The results are expressed as the percentage of cell surface-associated 
M protein and are expressed as the mean of three independent experiments. Error bars 
represent the standard error of the means (SEM) (Panels 6E and 6F). 
 
Figure 7: MERS-M and IBV-M sequence alignment (7A) and schematic drawings of the 
different IBV-M and MERS-M chimeras that were constructed (7B). First, the C-terminal 
domain of MERS-CoV M was replaced with the one of IBV-M (MERS-M/IBV-M) and the 
C-terminal domain of IBV-M was replaced by the one of MERS-CoV M with or without the 
mutation of the KxGxYR motif (IBV-M/MERS-M-KGYR and IBV-M/MERS-M, 
respectively). The first membrane-spanning segment of MERS-CoV M was replaced with the 
one of IBV-M in the context of the MERS-M-KGYR (TM1-IBV/MERS-M-KGYR) and the 
first membrane-spanning segment of IBV-M was replaced by the one of MERS-CoV M 
(TM1-MERS/IBV-M). All the chimeras were tagged at their C-terminal extremity with a 
VSVG epitope. 
 
Figure 8: Subcellular localization of IBV-M and MERS-CoV M proteins chimeras. The 
localization of the different chimeras in the TGN or in the ERGIC compartments was 
investigated by immunofluorescent double labeling by using an anti-VSVG antibody and an 
anti-TGN46 (8A) or by expressing the ERGIC-53 marker conjugated with GFP (8B). Bars 
indicate 20 µm. Pearson’s correlation coefficients were calculated for each combination of co-
staining (8C). 
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